/*

*/
   
/* ----------------Tag Styles------------------------------------------------------------- */

body {
	padding: 2px 0 0 0;
	margin: 0;
	line-height: 1.7em;
	color: #FFFFFF;
	background-color: #073315;
	background-repeat: repeat-x;
	font-family: Arial, Verdana, Helvetica, sans-serif;
	font-size: 0.75em;
}

a {
	color: #073315;
	font-weight:bold;
	background: inherit;
	text-decoration: none;
}

a:hover {
	color: #5B673D;
	background: inherit;
	text-decoration:none;
}

p {
	margin: 0 0 5px 0;
}

h1 {
	margin: 0;
	padding: 0 0 8px 0;
	font: normal 1.8em  "Trebuchet MS", Sans-Serif;
	color: #5a6f5e;
}

h2 {
	margin: 0;
	padding: 0 0 8px 0;
	font: bold 1.7em "Trebuchet MS", Sans-Serif;
	color: #073315;
}

ul { 
margin: 0 0 0 25px; 
padding: 0; 
list-style: square; 
}

img { 
border: 0; 
}

acronym {
cursor:  help;
}


.highlight {
color: #820304;
font-weight: bolder;
}

/* --------------divs (boxes)---------------------------------------------------------------- */

#content {
	width: 860px;
	background-color: #FFFFFF;
	border-top-style: none;
	border-right-style: none;
	border-bottom-style: none;
	border-left-style: none;
	margin-top: 0;
	margin-right: auto;
	margin-bottom: 0;
	margin-left: auto;
}

#header {
	height: 80px;
	padding:0;
	margin:0 0 1px 0;
	background-color: #073315;
}

#header h1 {
	font:bold 2.2em Arial, Verdana, Helvetica, sans-serif;
	color:#d3d3d3;
	padding: 22px 0 0 22px;
	margin: 0;
}

#pic {
	height: 151px;
	margin: 0 0 1px 0;
	background-image: url(images/bigimage.jpg);
}



/* Top Menu-------------------------------------------------------------- */

.headermenu {
	padding: 0;
	float: right;
	list-style-type: none;
	list-style-image: none;
	width: 570px;
	margin-top: 5px;
	margin-right: 5px;
	margin-bottom: 0;
	margin-left: 0;
}

.headermenu ul {
	margin: 0;
	padding: 0;
	float: right;
	list-style-type: none;
	list-style-image: none;
}

.headermenu li {
	float: right;
	padding-left: 1px;
	width: 140px;
	text-align: right;
}

.headermenu li a {
	color: #FFFFFF;
	font-weight: bold;
	text-transform:uppercase;
	display: block;
	height: 15px;
	line-height: 10px;
	padding: 40px 0 6px 6px;
	text-align: right;
	font-size: 1em;
	font-family: Arial, Verdana, Helvetica, sans-serif;
	background:none;
	text-decoration: none;
}

.headermenu li a:hover {
	color: #5a6f5e;
	font-weight: bold;
	display: block;
	background:none;
	text-decoration: none;
}

/* -------------Main Menu-------------------------------------------------------------- */

#menu{
	width: 860px;
	padding: 4px 0;
	margin: 0 0 6px 0;
	float: left;
	background-color: #073315;
}

#menu li{
	list-style: none;
	display: inline;
	margin: 0;
	text-align: right;
}

#menu li a{
	text-decoration: none;
	font-weight: bold;
	color: #FFFFFF;
	background-color: inherit;
	margin-top: 1px;
	margin-right: 1px;
	margin-bottom: 0;
	margin-left: 4px;
	padding-top: 6px;
	padding-right: 5px;
	padding-bottom: 6px;
	padding-left: 5px;
	font-size: 1.1em;
}

#menu li a:hover{
	color: #5a6f5e;
	background-color: inherit;
}

/*---------Right Side Content-----------------------------------------------------------*/

#rightside {
	float: right;
	width: 580px;
	margin-bottom: 10px;
	margin-right: 10px;
	border: 0px solid #5a6f5e;
}

.rightdata {
	margin: 0px 0 15px 0;
	min-height: 220px;
	color: News TLSF Participates in Virtual Living Room Online Discussion of National Healthcare Concerns  (December 29, 2008) In response to President-Elect Obama's call for community discussion of health care concerns, TLSF Project Director Deborah Vollmer Dahlke participated in an online webinar discussion hosted by the Intercultural Cancer Council.  This series of online discussions focused on cancer control topics identified as important by ICC members. Reports out from the discussion are being shared with the new Obama administration. TLSF Receives Grant from Pharmaceutical Research and Manufacturers of America  (November 28, 2008)  The Pharmaceutical Research and Manufacturers of America (PhRMA) provided Texas Life Science Foundation a $20,000 seed grant to support research on cancer clinical trial participation in Texas. PhRMA represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives
.   Events TLSF on The Stupid Cancer Show- March 9, 2009 Join TLSF Project Director Deborah Vollmer Dahlke for a discussion of clinical trial participation research and plans for a Texas Clinical Trial Network on The Stupid Cancer Show March 9 2009 at 8 pm CT.  Hosted by i[2]y Founder, Matthew Zachary, The Stupid Cancer Show is a pioneering new interactive talk radio broadcast finally giving voice to more than 1 million young adults affected by cancer. Join them every Monday night at 9pm/6pm (ET/PT) as they poke a stick at stupid cancer and make it hip to be a survivor.. It's free, it's fun and it's a mini social network because you can interact with other listeners in a live chatroom! For more information and program topics see . . .  stupidcancershow.com News TLSF Participates in Virtual Living Room Online Discussion of National Healthcare Concerns  (December 29, 2008) In response to President-Elect Obama's call for community discussion of health care concerns, TLSF Project Director Deborah Vollmer Dahlke participated in an online webinar discussion hosted by the Intercultural Cancer Council.  This series of online discussions focused on cancer control topics identified as important by ICC members. Reports out from the discussion are being shared with the new Obama administration. TLSF Receives Grant from Pharmaceutical Research and Manufacturers of America  (November 28, 2008)  The Pharmaceutical Research and Manufacturers of America (PhRMA) provided Texas Life Science Foundation a $20,000 seed grant to support research on cancer clinical trial participation in Texas. PhRMA represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.   Events TLSF on The Stupid Cancer Show- March 9, 2009 Join TLSF Project Director Deborah Vollmer Dahlke for a discussion of clinical trial participation research and plans for a Texas Clinical Trial Network on The Stupid Cancer Show March 9 2009 at 8 pm CT.  Hosted by i[2]y Founder, Matthew Zachary, The Stupid Cancer Show is a pioneering new interactive talk radio broadcast finally giving voice to more than 1 million young adults affected by cancer. Join them every Monday night at 9pm/6pm (ET/PT) as they poke a stick at stupid cancer and make it hip to be a survivor.. It's free, it's fun and it's a mini social network because you can interact with other listeners in a live chatroom! For more information and program topics see . . .  stupidcancershow.com;
	padding: 15px 15px 5px 10px;
	background-color: #FFFFFF;
	color: #5a6f5e;
}


#middle {
	float: left;
	width: 930px;
	margin-top: 0;
	margin-right: 15px;
	margin-bottom: 10px;
	margin-left: 15px;
}
.leftnav a {
	display: inherit;
	line-height: 4px;
}

.middledata {
	border: 1px solid #acacac;
	margin: 0px 0 15px 0;
	min-height: 220px;
	color: #333333;
	padding: 15px 15px 5px 10px;
	background-color: #FFFFFF;
}

.middlesubdata {
	clear: both;
	margin:0px 0 20px 0;
	padding: 5px 20px;
	border: 1px solid #d3d3d3;
	color: #333333;
	background-color: #FFFFFF;
} 

.thumb {
	margin: 0 12px 10px 0;
	width: 200px;
	height: 160px;
	float: left;
	clear: left;
	border: 4px solid #999999;
	background: #eee;
	color: #000;
}

.thumb:hover {
	border:4px solid #666666;
}

.rightinfo {
	color: #5a6f5e;
	border: 1px solid #d3d3d3;
	padding: 15px;
	margin: 0 0 15px 0;
	background-color: #FFFFFF;
}

		
/* --------------------Left Side Content----------------------------------------------- */


#leftside {
	float: left;
	width: 240px;
	margin-bottom: 10px;
	margin-top: 0px;
	margin-right: 0px;
	margin-left: 10px;
	border: 0px solid #5a6f5e;
}
.leftdata {
	color: #63666D;
	background-color: #FFFFFF;
	margin-top: 0;
	margin-right: 0;
	margin-bottom: 10px;
	margin-left: 0;
	padding: 8px;
}
.leftnav {
	color: #333333;
	background-color: #FFFFFF;
	margin-top: 0;
	margin-right: 0;
	margin-bottom: 10px;
	margin-left: 0px;
	padding: 8px;
	text-decoration: none;
	border: 1px solid #d3d3d3;
}
.image { 
float: left; 
margin: 0 9px 3px 0;
border: 2px solid #acacac; 
}
.style1 {
	font-style: normal;
	color: #FFFFFF;
	font-weight: bold;
}

/*---------The footer Data-------------------------------------------------------------------*/

#footer {
	clear: both;
	color: #CCCCCC;
	border-top: 1px solid #d3d3d3;
	background-color: #073315;
	padding-top: 10px;
	padding-right: 5px;
	padding-bottom: 10px;
	padding-left: 15px;
}

#footer .left { 
float: right; 
}
#footer li a {
	text-decoration: none;
	font-weight: bold;
	color: #FFFFFF;
	background-color: inherit;
	margin-top: 1px;
	margin-right: 1px;
	margin-bottom: 0px;
	margin-left: 4px;
	padding-top: 6px;
	padding-right: 5px;
	padding-bottom: 6px;
	padding-left: 5px;
	font-size: 1.1em;
}
#footer li a:hover {
	color: #5a6f5e;
	background-color: inherit;
}